Unlocking Value: A Look into Share Transactions in 2025

Unlocking Value: A Look into Share Transactions in 2025 Transaction in Own Shares On 07 March 2025, Shell plc (the ‘Company’) made an announcement regarding its purchase of a significant number of its own shares for cancellation. The transaction details are as follows: Aggregated information on Shares purchased according to

Read More »

Join VERSES at the 37th Annual Roth Conference – March 16-18th!

Join VERSES at the 37th Annual Roth Conference – March 16-18th! VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation intelligent software systems, announces that CEO and Founder Gabriel René and CFO James Christodoulou

Read More »

Breaking News: CenterPoint Energy Surpasses 50% Completion Milestone for Greater Houston Resiliency Initiative Ahead of 2025 Hurricane Season!

Breaking News: CenterPoint Energy Surpasses 50% Completion Milestone for Greater Houston Resiliency Initiative Ahead of 2025 Hurricane Season! Description: More than 14,200 stronger, storm-resilient poles installed; 2,200+ miles of high-risk vegetation cleared; 2,170+ automated reliability devices installed; and 280+ miles of power lines undergrounded. When completed by June 1, GHRI

Read More »

Breaking News: Sprott Renews Normal Course Issuer Bid for 2025!

Breaking News: Sprott Renews Normal Course Issuer Bid for 2025! Description: TORONTO, March 06, 2025 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) announced today that the Toronto Stock Exchange (“TSX”) has approved the Company’s notice of intention to make a normal course issuer bid (“NCIB”). Pursuant

Read More »

Breaking News: Oruka Therapeutics Announces Impressive Financial Results for 2024 and Exciting Corporate Updates!

Breaking News: Oruka Therapeutics Announces Impressive Financial Results for 2024 and Exciting Corporate Updates! Description ORKA-001, targeting IL-23p19, Phase 1 trial ongoing, with pharmacokinetic (PK) data expected in 2H 2025. ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout in 2H 2026 that provides multiple opportunities to show

Read More »

Attention Investors: Important Investigation Alert from Levi and Korsinsky!

Attention Investors: Important Investigation Alert from Levi and Korsinsky! NEW YORK, NY / ACCESS Newswire / March 6, 2025 Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex Incorporated (“Teleflex Incorporated”) (NYSE:TFX) concerning possible violations of federal securities laws. On February 27, 2025, the company announced

Read More »

SEARCH

Receive the latest market news

Subscribe To Our Newsletter

Get notified about market movers